PICARIELLO, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 1.774
EU - Europa 1.106
AS - Asia 289
AF - Africa 4
SA - Sud America 4
Totale 3.177
Nazione #
US - Stati Uniti d'America 1.773
RU - Federazione Russa 467
PL - Polonia 130
IE - Irlanda 119
SE - Svezia 119
IT - Italia 104
SG - Singapore 90
HK - Hong Kong 73
CN - Cina 66
DE - Germania 50
UA - Ucraina 36
JO - Giordania 31
FI - Finlandia 27
GB - Regno Unito 20
IN - India 14
BE - Belgio 13
ES - Italia 11
TR - Turchia 10
CH - Svizzera 3
CI - Costa d'Avorio 3
NL - Olanda 3
BR - Brasile 2
CO - Colombia 2
FR - Francia 2
JP - Giappone 2
VN - Vietnam 2
CA - Canada 1
CZ - Repubblica Ceca 1
IR - Iran 1
RO - Romania 1
SC - Seychelles 1
Totale 3.177
Città #
Santa Clara 335
Fairfield 175
Chandler 172
Warsaw 130
Dublin 118
Ashburn 101
Woodbridge 85
Cambridge 84
Seattle 79
Singapore 78
Jacksonville 74
Ann Arbor 70
Houston 69
Wilmington 65
Hong Kong 46
Altamura 29
Lawrence 28
Princeton 27
Boardman 26
Buffalo 26
Florence 22
Beijing 21
Shanghai 17
Boston 16
Kent 14
Medford 13
Brussels 12
Munich 11
Barcelona 10
West Jordan 10
New York 9
San Diego 9
Los Angeles 8
Mumbai 8
Bremen 7
Izmir 7
Milan 5
Moscow 5
Bari 4
Corigliano Calabro 4
Fontebuona 4
Helsinki 4
Abidjan 3
Bern 3
Fuzhou 3
Hillsboro 3
London 3
Norwalk 3
Pune 3
Viareggio 3
Washington 3
Yubileyny 3
Cranford 2
Dong Ket 2
Falls Church 2
Farra di Soligo 2
Frankfurt Am Main 2
Laurel 2
New Delhi 2
Sesto Fiorentino 2
Americana 1
Andover 1
Auburn Hills 1
Baotou 1
Barranquilla 1
Bogotá 1
Cluj-Napoca 1
Corciano 1
Düsseldorf 1
Groningen 1
Gurugram 1
Kish 1
Kunming 1
La Spezia 1
Lappeenranta 1
Naaldwijk 1
Naples 1
New Bedfont 1
Newark 1
Old Bridge 1
Palma De Mallorca 1
Pasadena 1
Pescara 1
Philadelphia 1
Phoenix 1
Pisa 1
Rome 1
Rui'an 1
Saint Petersburg 1
San Mateo 1
Tokyo 1
Toronto 1
Verona 1
Totale 2.116
Nome #
RNA sequencing reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 278
A comparison of methods for the analysis of low abundance proteins in desmoid tumor cells. 151
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 139
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 135
Telomerase repeat amplificationprotocol (TRAP): A new molecular marker for parathyroid carcinoma. 134
Estrogen metabolism in human colorectal cancer cells. 131
A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. 119
Apoptosis induced by sulindac sulfide in epithelial and mesenchymal cells from human abdominal neoplasms. 116
D13Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 115
Redox regulation of MMP-3/TIMP-1 ratio in intestinal myofibroblasts: Effect of N-acetylcysteine and curcumin 110
Desmoid Tumors in Familial Adenomatous Polyposis 110
Microencapsulation of human parathyroid cells:an "in vitro" study. 109
Role of N-acetylcysteine and GSH redox system on total and active MMP-2 in intestinal myofibroblasts of Crohn's disease patients 106
Telomerase repeat amplification protocol (TRAP): A new molecular marker for parathyroid carcinoma. 105
Oxidative state and IL-6 production in intestinal myofibroblasts of Crohn's disease patients. 98
ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components 96
ESTROGEN SYNTHESIS IN HUMAN COLON CANCER EPITHELIAL CELLS 93
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 89
Desmoid tumours in familial adenomatous polyposis. 88
AZIDOTHYMIDINE INDUCES APOPTOSIS AND INHIBITS CELL GROWTH AND TELOMERASE ACTIVITY OF HUMAN PARATHYROID CANCER IN CELL CULTURE 80
Oxidative state and IL-6 production in intestinal myofibroblasts of Crohn's Dsease patients 75
Growth response of colon cancer cell lines to selective estrogen modulators 74
Selective estrogen receptor modulators in desmoid tumours 66
RuvBL1 haploinsufficiency improves mTOR-driven NASH-HCC development in mice 61
Role of GSH and oxidative state related on MMP-2 activity in intestinal myofibroblasts of Crohn's disease patients 60
Isoforms of the orphan nuclear receptor COUP-TFII differentially modulate pancreatic cancer progression 58
Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures. 58
In vitro bioeffects of the antiestrogen LY117018 on desmoid tumor and colon cancer cells. 58
RUVBL1 correlates with chaperones expression in HCC and its activity is required for HSF1-mediated stress response 54
T.03.4 SPHINGOSINES, COUP-TFII AND PANCREATIC CANCER 48
Targeting the AAA+ ATPase RuvBL1 reduces mTOR-driven NASH-HCC development in mice 43
RuvBL1 haploinsufficiency promotes hepatic lipid catabolism hampering NASH-HCC progression in mice 43
Targeting RuvBL1 reduces mTOR-driven NASH-HCC progression in conditional PTEN-KO mice 35
OC.05.6: TARGETING RUVBL1 REDUCES MTOR-DRIVEN NASH-HCC DEVELOPMENT IN MICE 34
null 31
Totale 3.200
Categoria #
all - tutte 9.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.170


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020344 0 0 0 0 48 60 51 61 47 26 40 11
2020/2021263 27 18 22 26 6 30 12 26 19 40 16 21
2021/2022186 9 16 7 8 5 12 7 12 8 12 49 41
2022/2023623 42 114 19 65 50 104 75 43 78 2 20 11
2023/2024263 13 22 35 6 15 29 15 58 0 34 18 18
2024/20251.047 54 153 106 298 436 0 0 0 0 0 0 0
Totale 3.200